ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
Clinical trial NCT07448610 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07448610
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2032-05-03
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.